Schizophrenia and Bipolar Affective Disorder: Perspectives for the Development of Therapeutics
Journal:
Current Molecular Medicine
Volume:
3
Page:
393-407
Author(s):
S. Sundram, P. R. Joyce and M. A. Kennedy
Intravenous Immunoglobulin Preparations and Autoimmune Disorders: Mechanisms of Action
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
239-247
Author(s):
C. Ibanez and B. J. Montoro-Ronsano
Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
211-219
Author(s):
A. Evangeliou and D. Vlassopoulos
Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
115-128
Author(s):
Yoshiyasu Aoki and Giovanna Tosato
Arterial Stiffness and Cardiovascular Drugs
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1049-1063
Author(s):
Thomas Weber, Johann Auer, Geza Eisserer, Robert Berent, Bernd Eber and Michael F. O´Rourke
Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1103-1114
Author(s):
Arthur G. Taveras, Paul Kirschmeier and Charles M. Baum
The Genomic Approaches to Major Depression
Journal:
Current Pharmacogenomics
Volume:
1
Page:
67-74
Author(s):
Chen-Jee Hong and Shih-Jen Tsai
Gene Therapy and Biologic Therapy with Interleukin?4
Journal:
Current Gene Therapy
Volume:
2
Page:
437-450
Author(s):
Hideho Okada and Naruo Kuwashima
Depressed or Demented: Common CNS Drug Targets? !
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
575-592
Author(s):
Miao-Kun Sun and Daniel L. Alkon
Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
251-272
Author(s):
Stefano Laureti, Fausto Santeusanio and Alberto Falorni